Pelthos Therapeutics Inc. Expense Breakdown
No Expense Breakdown for PTHS on this site yet.
- 2026-06-30: Commercial Operations $3.61M; Research and Development Operations $0.00.
- 2025-06-30: Commercial Operations $0.00; Research and Development Operations $0.00.
Source checked: the stored Expense Breakdown page for PTHS.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Commercial Operations | Research and Development Operations |
|---|
| 2026-06-30 | $3.61M | $0.00 |
|---|
| 2025-06-30 | $0.00 | $0.00 |
|---|
Research and development: each quarter (3 month)
| Quarter end | Commercial Operations | Research and Development Operations |
|---|
| 2026-06-30 | $0.00 | $600.00K |
|---|
| 2025-06-30 | $0.00 | $515.00K |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Commercial Operations | Research and Development Operations |
|---|
| 2026-06-30 | $27.67M | $0.00 |
|---|
| 2025-06-30 | $0.00 | $2.72M |
|---|